These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27999794)

  • 21. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.
    Zhang L; Cai JQ; Zhao JJ; Bi XY; Tan XG; Yan T; Li C; Zhao P
    J Surg Oncol; 2010 Mar; 101(3):233-8. PubMed ID: 20169539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus infection and intrahepatic cholangiocarcinoma.
    Zhou HB; Hu JY; Hu HP
    World J Gastroenterol; 2014 May; 20(19):5721-9. PubMed ID: 24914333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Association between hepatitis B virus infection and risk of pancreatic cancer: a meta-analysis].
    Zhuang H; Shi Z; Hu P; Ren H; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):416-9. PubMed ID: 25203703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral venous sinus thrombosis may be associated with hepatitis B virus infection: a preliminary finding.
    Shan F; Gao C; Long Y; Huang L; Zheng Y; Chen M; Fan Y; Yin J
    Neurol Res; 2015 Jun; 37(6):510-3. PubMed ID: 25591420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible reactivation of potential hepatitis B virus occult infection by tumor necrosis factor-alpha blocker in the treatment of rheumatic diseases.
    Kim YJ; Bae SC; Sung YK; Kim TH; Jun JB; Yoo DH; Kim TY; Sohn JH; Lee HS
    J Rheumatol; 2010 Feb; 37(2):346-50. PubMed ID: 20008922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
    Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus.
    Liu XF; Zou SQ; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):285-9. PubMed ID: 14599986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
    Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
    Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.
    Hsing AW; Zhang M; Rashid A; McGlynn KA; Wang BS; Niwa S; Ortiz-Conde BA; Goedert JJ; Fraumeni JF; O'Brien TR; Gao YT
    Int J Cancer; 2008 Apr; 122(8):1849-53. PubMed ID: 18076042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and significance of hepatitis B virus genes in human primary intrahepatic cholangiocarcinoma and its surrounding tissue].
    Wang W; Gu G; Hu M
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):127-30. PubMed ID: 9206046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of hepatitis B virus integration sites in hilar cholangiocarcinoma tissues].
    Qu ZL; Cui NQ; Xi ZH; Du Z
    Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):741-5. PubMed ID: 22168942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.